Compare Nucor Corporation (NUE) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nucor Corporation vs Oscar Health Inc — how do they compare? Nucor Corporation trades at $257.08 (market cap $58.17B), while Oscar Health Inc trades at $31.72 (market cap $10.19B). The key difference: Nucor Corporation is far larger — about 5.7× Oscar Health Inc's market cap, and Nucor Corporation pays a 0.87% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| NUE | OSCR | |
|---|---|---|
Market Cap | $58.17B | $10.19B |
Sector | Basic Materials | Health |
52-Week High | $274.74 | $33.01 |
52-Week Low | $131.78 | $10.85 |
Enterprise Value | $62.58B | $6.54B |
Dividend Yield | 0.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nucor Corporation (NUE) trades at $256.40, down 1.79% on the day, with a bullish technical signal supported by moving averages and strong institutional interest. The company shows improving fundamentals with recent earnings beats (Q1 and Q2 2026) and projected revenue growth to $36.1B in 2026. Analyst consensus remains positive with a $277.57 price target, though recent trade tensions and cyclical steel industry challenges present headwinds.
NUE offers value with reasonable valuation multiples (P/E 20.46, P/S 1.63) and strong profitability metrics (ROE 13.52%). Key risks include exposure to steel price volatility and macroeconomic sensitivity, but infrastructure demand and tariff protections provide tailwinds. Institutional accumulation and dividend stability support the investment case for long-term investors.
Oscar Health (OSCR) trades at $33.01, up 2.36% today and approaching its 52-week high of $33.10. The stock shows strong technical momentum with bullish moving averages and has surged 109% year-to-date. Fundamentally, revenue grew from $11.7B in 2025 to $15.3B in 2026, with net income turning positive at $551M. Recent earnings beats and membership growth to 2.96 million support the bullish case, though valuation metrics like P/E of 25.39 and P/B of 4.97 suggest premium pricing.
Outlook remains positive with strong revenue growth and profitability improvements, but risks include high valuation multiples and dependence on sustained membership growth. Analyst consensus is mixed with 27% buy ratings and a $30.67 price target below current levels, indicating caution despite technical strength. Key catalysts include continued operational efficiency gains and AI integration, while medical cost management remains critical.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
